Subscriptions are live: We're on the subscription model now, early-access price $24.99/month, with day, week, and longer plans too. New accounts start with 5 free premium days. Prefer to donate? Donations grant premium time and are logged on your profile page.

$LABT

Lakewood-Amedex Biotherapeutics Inc. Common Stock

XNASHealth CarePharmaceutical Preparations

$2.23-3.68%$0.0850Prev $2.31LIVE Full chart Live alerts
No recent price bars, the chart lights up when LABT starts printing.

Why is LABT down today? It is at $2.23 (-3.68%), and our scanner flagged it 72 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment LABT spikes, and full due diligence on LABT — key stats, earnings, dilution and insider activity. Free.

Free alerts

Get free $LABT alerts the moment volume spikes

Our scanner flagged $LABT 72 times in the last 30 days. Create a free account to track $LABT, build a watchlist, and get instant unusual-volume alerts — plus 5 free premium days, no card needed.

Real-time RVOL & momentum alerts Personal watchlist & price alerts
Sign up free with email

No card · 5 premium days · join 800+ traders

Key Stats

Price & performance
Price
$2.23
Change today
-3.68%
Previous close
$2.31
52-week range
$0.366 – $9.82
Valuation & dividend
Market cap
$16M
Ownership & volume
Short interest
24K
▼ -36% vs prior · as of 2026-07-15
Short % of float
0.3%
Days to cover
1.0d
Avg daily volume
2.7M
Next earnings
Aug 28 · in 22d
Classification
Sector
Health Care
Industry
Pharmaceutical Preparations
Exchange
XNAS
Relative volumevs this time of day
5m
0.0x
15m
0.0x
1h
0.1x
1D
0.0x

Get free LABT + market alerts in your inbox

The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.

No spam. Unsubscribe anytime. Not investment advice.

Why is $LABT down today?

Here is the latest on LABT from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for LABT today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.

Likely catalystPioneering Bisphosphocin® Compounds Advancing a novel class of fast- acting antimicrobials toaddress the global threat ofresistance 1, from the latest SEC filing. Read it →
Why is $LABT moving? →▶ Replay the moveAuto-generated from live scanner data. Not investment advice.
Trading profileLow float · 7.0M shNot shortableNo SSRBorrow via Alpaca · SSR from Reg SHO 201
$LABT is down 3.7% today and has a recent share offering on file. See who may be selling into moves →

Dilution watch

Recent offering

Recent priced share offering — a one-time sale that has already completed (not ongoing). If $LABT runs, these filings show who may be positioned to sell new or newly-registered shares into the move.

Sourced from SEC EDGAR filings (last 9 months); terms read straight from the filing text where available. Ongoing = an at-the-market (ATM) program still selling over time or a live shelf, so it can keep diluting; Completed = a one-time priced sale that already finished. A shelf (S-3) stays effective ~3 years. Form type signals dilution capacity, not an exact share count, and we can't confirm how much of a shelf or ATM remains unused. Not investment advice.

$LABT Sentiment

Bearish
Bearish27Bullish
📰 News: 0 bull · 0 bearToday: -3.7%👥 Community: 0 bull · 0 bear

Blend of news sentiment, today’s move, and community votes. Not investment advice.

$LABT Activity

News, unusual-volume alerts, AI-trader trades and community chatter — the whole story, newest first.

Alert· 13d ago -1.59%
$LABT moved -1.59% in 1 min (Level 1) at 10:00 AM ET
at $2.88
Alert· 13d ago 2.0× RVOL
LABT hit 2.000x RVOL at 2:43 PM ET
at $2.94
Alert· 13d ago -4.05%
$LABT moved -4.05% in 1 min (Level 1) at 12:31 PM ET
at $2.86
Alert· 13d ago 3.4× RVOL
LABT hit 3.346x RVOL at 12:31 PM ET
at $2.87
Alert· 13d ago
The Watcher SOLD $LABT at $3.2200 __THOTH_JSON__{"side":"sell","strategyLabel":"The Rider · scalp","reason":"trail_break","shares":391,"instance":"Rider"}
at $3.22
Alert· 14d ago
The Watcher BOUGHT $LABT at $3.3700 __THOTH_JSON__{"side":"buy","strategyLabel":"The Rider · scalp","reason":"scalp entry · support-reclaim","shares":391,"instance":"Rider"}
at $3.37
Alert· 14d ago -2.06%
$LABT moved -2.06% in 1 min (Level 2) at 10:17 AM ET
at $3.44
Alert· 14d ago 13.2× RVOL
LABT hit 13.182x RVOL at 9:53 AM ET
at $3.31
Alert· 14d ago
The Watcher SOLD $LABT at $3.3400 __THOTH_JSON__{"side":"sell","strategyLabel":"The Rider · scalp","reason":"trail_break","shares":456,"instance":"Rider"}
at $3.34
Alert· 14d ago
The Watcher BOUGHT $LABT at $3.4100 __THOTH_JSON__{"side":"buy","strategyLabel":"The Rider · scalp","reason":"scalp entry · support-reclaim","shares":456,"instance":"Rider"}
at $3.41
Alert· 14d ago +6.15%
$LABT moved +6.15% in 1 min (Level 5) at 9:36 AM ET
at $3.40
Alert· 14d ago +2.30%
$LABT moved +2.30% in 1 min (Level 1) at 9:20 AM ET
at $3.35
Alert· 14d ago 3.0× RVOL
LABT hit 2.999x RVOL at 9:20 AM ET
at $3.30
Alert· 14d ago 5.8× RVOL
LABT hit 5.757x RVOL at 6:15 AM ET
at $3.37
Alert· 14d ago 2.7× RVOL
LABT hit 2.730x RVOL at 4:05 AM ET
at $3.07
Alert· 14d ago -6.89%
$LABT moved -6.89% in 1 min (Level 1) at 7:23 PM ET
at $3.38
Alert· 14d ago 36.3× RVOL
LABT hit 36.331x RVOL at 7:09 PM ET
at $3.63
Alert· 14d ago 3.2× RVOL
LABT hit 3.174x RVOL at 6:56 PM ET
at $3.51
Alert· 14d ago -1.9% vs EMA
$LABT near 200 EMA: -1.90% from 200 EMA at 6:50 PM ET
at $3.36
Alert· 14d ago
The Watcher SOLD $LABT at $3.3200 __THOTH_JSON__{"side":"sell","strategyLabel":"The Rider · day","reason":"trail_break","shares":305,"instance":"Rider"}
at $3.32
Alert· 14d ago +1.76%
$LABT moved +1.76% in 1 min (Level 1) at 6:34 PM ET
at $3.34
Alert· 14d ago 21.7× RVOL
LABT hit 21.699x RVOL at 6:08 PM ET
at $3.41
Alert· 14d ago 6.3× RVOL
LABT hit 6.351x RVOL at 5:59 PM ET
at $3.41
Alert· 14d ago +1.0% vs EMA
$LABT crossed above 200 EMA (+1.05% vs EMA) at 5:36 PM ET
at $3.50
Alert· 14d ago +7.26%
$LABT moved +7.26% in 1 min (Level 1) at 5:41 PM ET
at $3.45
News· SEC EDGAR· 21d ago
Lakewood-Amedex Biotherapeutics Inc.: Pioneering Bisphosphocin® Compounds Advancing a novel class of fast- acting antimicrobials toaddress the global threat ofresistance 1
News· SEC EDGAR· 49d ago
Lakewood-Amedex Biotherapeutics Inc. filed an 8-K: Shareholder Rights Change, Charter / Bylaw Change
News· SEC EDGAR· 75d ago
Lakewood-Amedex Biotherapeutics Inc. filed a Quarterly report (10-Q)
News· SEC EDGAR· 99d ago
Lakewood-Amedex Biotherapeutics Inc. filed an 8-K: Executive / Board Change

Related PHARMACEUTICAL stocks

Also moving today

The tickers our scanner is lighting up most over the last 48 hours.

LABT stock FAQ

Why is $LABT down today?

Here is the latest on LABT from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for LABT today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.

What is the LABT stock price today?

LABT last traded at $2.23, down 3.68% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).

When does LABT report earnings?

Lakewood-Amedex Biotherapeutics Inc. Common Stock (LABT) is next expected to report earnings on Friday, August 28, 2026, about 22 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.

Where can I see live LABT alerts?

The LABT Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged LABT 72 times in the last 30 days.

What exchange is LABT on?

LABT (Lakewood-Amedex Biotherapeutics Inc. Common Stock) trades on XNAS, with a market cap of about $16M in the PHARMACEUTICAL PREPARATIONS sector.

Is LABT good for day trading?

That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge LABT for yourself. This is not investment advice.

Live data from TheDesperateTrader scanner. Not investment advice.